By S.Z. Berg
NEW YORK (MainStreet)--The Food and Drug Administration (FDA) announced a proposal to revise drug labeling regulations for generic drugs to create parity among brand name and generic drug manufacturers. The revised rule would allow...
WASHINGTON (MedPage Today) -- The FDA has expanded the indications for oral lubiprostone (Amitiza) to include constipation in chronic pain patients taking opioids, according to the drug's manufacturers.
The United States said on Tuesday it was considering its response to the Supreme Court ruling that U.S. drug manufacturers warn is the latest sign of a "deteriorating" environment for intellectual property rights in the country.
(MedPage Today) -- The FDA program that monitors drug safety risks is ineffective because drug manufacturers fail to comply with the program and the agency fails to enforce it, according to a government report.
(MedPage Today) -- The targeted drug sorafenib (Nexavar) prolonged progression-free survival in patients with thyroid cancer resistant to radioactive iodine therapy in a phase III trial, the drug's manufacturers said.
Oops! Unable to complete your request. Please refresh your browser.